These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3610234)

  • 1. Production of human--human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization of peripheral blood lymphocytes.
    Terashima M; Shimada S; Komatsu H; Osawa T
    Immunol Lett; 1987 May; 15(1):89-93. PubMed ID: 3610234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
    Strike LE; Devens BH; Lundak RL
    J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes.
    Fuson EW; Shaw MW; Hubbard RA; Lamon EW
    Clin Exp Immunol; 1979 Oct; 38(1):158-65. PubMed ID: 316751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
    Astaldi GC; Wright EP; Willems C; Zeijlemaker WP; Janssen MC
    J Immunol; 1982 Jun; 128(6):2539-42. PubMed ID: 6804563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of human heterophile antibodies. III. In vitro specific stimulation and immortalization of human lymphocytes.
    Mori T; Kanzaki H; Mori E
    Jpn J Exp Med; 1989 Apr; 59(2):65-72. PubMed ID: 2545960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA hybridomas: a method for generation in high numbers.
    Colwell DE; Gollahon KA; McGhee JR; Michalek SM
    J Immunol Methods; 1982 Oct; 54(2):259-66. PubMed ID: 6757324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro stimulated lymphocytes as a source of human hybridomas.
    Kozbor D; Roder JC
    Eur J Immunol; 1984 Jan; 14(1):23-7. PubMed ID: 6319153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
    Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
    J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of specific IgG-producing human hybridomas by fusions of lymphocytes from actively immunized persons.
    Jahn S; Settmacher U; Haensel K; Kiessig S; Grunow R; Von Baehr R
    Hybridoma; 1989 Oct; 8(5):529-33. PubMed ID: 2680900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of antibody production accompanied by chromosome loss in a cloned hybrid line secreting antibodies to sheep red blood cells.
    Nowak JS
    Experientia; 1985 Jan; 41(1):88-9. PubMed ID: 3967746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the immunogenic properties of sheep erythrocytes by sonic disruption.
    Nagase F; Nakashima I; Nagase N; Kato N
    Microbiol Immunol; 1982; 26(2):139-51. PubMed ID: 6979670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-secreting cell precursor frequencies among the sheep-erythrocyte-binding cells after immunization.
    Martínez-Maza O; Fehniger TE; Ashman RF
    Scand J Immunol; 1983 Apr; 17(4):345-54. PubMed ID: 6682242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the functional activities of human T cells after their interaction with SRBC.
    Silva A; Lopez-Botet M; Alvarez J; de Landazuri MO
    J Immunol; 1981 Feb; 126(2):393-7. PubMed ID: 6450242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies in the development of human monoclonal antibodies.
    Jahn S; Grunow R; Kiessig ST; Settmacher U; Von Baehr R
    Dev Biol Stand; 1990; 71():3-7. PubMed ID: 2401386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice.
    Lycke N; Lindholm L; Holmgren J
    Clin Exp Immunol; 1985 Oct; 62(1):39-47. PubMed ID: 4064375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of monoclonal antibodies specific for types 6 and 19 pneumococcal capsular polysaccharides.
    Milligan GN; Braley-Mullen H
    Mol Immunol; 1989 Sep; 26(9):799-807. PubMed ID: 2601723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology.
    Brams P; Pettijohn DE; Brown M; Olsson L
    J Immunol Methods; 1987 Apr; 98(1):11-22. PubMed ID: 2435806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro immunization of human lymphocytes with human lung cancer cell line A549.
    Kawahara H; Shirahata S; Tachibana H; Murakami H
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):8-13. PubMed ID: 1576323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro stimulation prior to fusion generates antigen-binding human-human hybridomas.
    Wasserman RL; Budens RD; Thaxton ES
    J Immunol Methods; 1986 Nov; 93(2):275-83. PubMed ID: 3534099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.